Factor VII or VIIa Gla domain variants

Details for Australian Patent Application No. 2004247799 (hide)

Owner Bayer HealthCare LLC

Inventors Bornaes, Claus; Haaning, Jesper Mortensen; Andersen, Kim Vilbour

Agent Spruson & Ferguson

Pub. Number AU-B-2004247799

PCT Pub. Number WO2004/111242

Priority PA 2004 00930 15.06.04 DK; 60/479,780 19.06.03 US

Filing date 18 June 2004

Wipo publication date 23 December 2004

Acceptance publication date 3 December 2009

International Classifications

C07K 14/745 (2006.01) Peptides having more than 20 amino acids

A61K 38/48 (2006.01) Medicinal preparations containing peptides

C12N 9/64 (2006.01) Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 15/57 (2006.01) Mutation or genetic engineering - acting on peptide bonds (3.4)

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

19 January 2006 PCT application entered the National Phase

  PCT publication WO2004/111242 Priority application(s): WO2004/111242

13 November 2008 Assignment before Grant

  Maxygen Holdings Ltd. The application has been assigned to Bayer HealthCare LLC

3 December 2009 Application Accepted

  Published as AU-B-2004247799

1 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004247801-Proteases

2004247762-Methods for the production of insulin in plants